BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Dec 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-11-29

Reporting Person: MEIER RICHARD A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-29	Common Stock	M	5000	$16.92	Acquired	23650	Direct
2012-11-29	Common Stock	S	5000	$49.1684	Disposed	18650	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-29	Stock Option (right to buy)	$16.92	M	5000	Disposed	2016-12-13	Common Stock (5000)	Direct

Footnotes

F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $49.151 to $49.19. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the price range.

F2: Options vest 1/4th each on March 14, 2007, June 14, 2007, September 14, 2007 and December 14, 2007.